A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation

X Tang, H Dai, E Knight, F Wu, Y Li, T Li… - Briefings in …, 2024 - academic.oup.com
Artificial intelligence (AI)-driven methods can vastly improve the historically costly drug
design process, with various generative models already in widespread use. Generative …

Scaffold-Lab: Critical Evaluation and Ranking of Protein Backbone Generation Methods in A Unified Framework

Z Zheng, B Zhang, B Zhong, K Liu, Z Li, J Zhu, J Yu… - bioRxiv, 2024 - biorxiv.org
De novo protein design has undergone a rapid development in recent years, especially for
backbone generation, which stands out as more challenging yet valuable, offering the ability …